Expression of inducible nitric oxide synthase in colorectal cancer and its association with prognosis

Scandinavian Journal of Gastroenterology

Volumn 35, Issue 11, 2000, Pages 1204-1211

  Ropponen, K M ^a   Kellokoski, J K ^a   Lipponen, P K ^a   Eskelinen, M J ^a   Alanne, L ^a   Alhava, E M ^a   Kosma, V M ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Colorectal carcinoma; Inducible nitric oxide synthase; Prognosis

Indexed keywords

NITRIC OXIDE SYNTHASE;

ARTICLE; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; COLORECTAL CANCER; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MITOSIS INDEX; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR ASSOCIATED LEUKOCYTE;

EID: 0033638998     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655200750056709     Document Type: Article

References (41)

1. Nitric oxide synthases in Kaposi's sarcoma are expressed predominantly by vessels and tissue macrophages
2. Nitric oxide synthase in mammals
3. Nitric oxide: Physiology, pathophysiology and pharmacology
4. Selective expression of inducible nitric oxide synthase in human prostate carcinoma
5. Expression of inducible nitric oxide synthase in breast cancer correlates with metastatic disease
6. Expression of differential nitric oxide synthase isoforms in human normal gastric mucosa and gastric cancer tissue
7. Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer
8. Increased level of exhaled nitric oxide and up-regulation of inducible nitric oxide synthase in patients with primary lung cancer
9. Frequent nitric oxide synthase-2 expression in human colon adenomas: Implication for tumor angiogenesis and colon cancer progression
10. Nitric oxide synthase activity in human renal cell carcinoma
11. Nitric oxide synthase activity in fresh cells from ovarian tumor tissue: Relationship of enzyme activity with clinical parameters of patients with ovarian cancer
12. Inducible nitric oxide synthase (iNOS) expression may predict distant metastasis in human melanoma
13. Cancer of the colon: The influence of the no-touch isolation technique on survival rates
14. Correlation of MIB-1 antigen expression with transcription factors Skn-1, Oct-1, AP-2 and HPV type in cervical intraepithelial neoplasia
15. p21/WAF1 expression in human colorectal carcinoma: Association with p53, transcription factor AP-2 and prognosis
16. p53 expression and cell proliferation as prognostic factors in laryngeal squamous cell carcinoma
17. Prognostic value of tumour infiltrating lymphocytes (TILs) in colorectal cancer
18. Prognosis of ovarian carcinomas: Prediction by histoquantitative methods
19. Statistical aspects of the analysis of data from retrospective studies of disease
20. Regression models and life tables with discussion
21. Nitric oxide synthase activity and expression in human colorectal cancer
22. Nitric oxide in tumour biology and cancer therapy. Part 2: Therapeutic implications
23. Role of nitric oxide in tumour progression: Lessons from human tumours
24. Localisation of nitric oxide synthase (NOS) isoforms and co-expression of the low affinity IgE receptor (CD23) in primary breast cancer
25. Relationship between p53 mutations and inducible nitric oxide synthase in human colorectal cancer
26. Inducible nitric oxide synthase with transitional cell carcinoma of the bladder
27. The altered tumoricidal capacity of macrophages isolated from tumor-bearing mice is related to reduced expression of the inducible nitric oxide synthase gene
28. Identification of a novel AP-2 consensus DNA binding site
29. p21 WAF/Cip1 is associated with cyclin D1(CCND1) expression and tubular differentiation but is independent of p53 overexpression in human breast carcinoma
30. p53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cells
31. Nitric oxide-induced apoptosis in human pancreatic carcinoma cell lines is associated with a G1-arrest and increase of the cyclin-dependent kinase inhibitor p21(WAF/CIP1)
32. Nitric oxide synthase in human breast cancer is associated with tumor grade, proliferation rate and expression of progesterone receptors
33. Up-regulation of inducible nitric oxide synthase expression in cancer-prone p53 knockout mice
34. p53 expression in nitric oxide-induced apoptosis
35. Nitric oxide synthase activity in human gynecological cancer
36. Nitric oxide synthase activity in human breast cancer
37. Frequent expression of inducible nitric oxide synthase in esophageal squamous cell carcinomas
38. Transfection with the inducible nitric oxide synthase gene suppresses tumorigenity and abrogates metastasis by K-1735 murine melanoma cells
39. Roles of nitric oxide in tumor growth
40. Cytoplasmic localization of endothelial constitutive nitric oxide synthase in endometrial carcinomas